SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933
SEC Accession No. 0001193125-11-271825
Filing Date
2011-10-14
Accepted
2011-10-14 16:55:26
Documents
32
Filing Date Changed
2011-10-14

Document Format Files

Seq Description Document Type Size
1 FORM S-1 d237820ds1.htm S-1 2390462
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION d237820dex31.htm EX-3.1 80765
3 AMENDED AND RESTATED BYLAWS d237820dex33.htm EX-3.3 136356
4 AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT d237820dex42.htm EX-4.2 202729
5 FORM OF COMMON STOCK WARRANT d237820dex43.htm EX-4.3 63937
6 FORM OF SERIES B PREFERRED STOCK WARRANT d237820dex44.htm EX-4.4 79163
7 CONVERTIBLE NOTE LOAN AGREEMENT d237820dex45.htm EX-4.5 48799
8 AMENDED AND RESTATED 1997 STOCK OPTION /STOCK ISSUANCE PLAN d237820dex101.htm EX-10.1 76648
9 AMENDED AND RESTATED 2002 EQUITY INCENTIVE PLAN d237820dex102.htm EX-10.2 78238
10 AMENDED AND RESTATED EMPLOYMENT AGREEMENT - THOMAS J. SCHALL, P.H.D. d237820dex106.htm EX-10.6 79317
11 AMENDED AND RESTATED EMPLOYMENT AGREEMENT - MARKUS J. CAPPEL, P.H.D. d237820dex107.htm EX-10.7 79817
12 AMENDED AND RESTATED EMPLOYMENT AGREEMENT - SUSAN M. KANAYA d237820dex108.htm EX-10.8 79554
13 AMENDED AND RESTATED EMPLOYMENT AGREEMENT - JUAN C. JAEN, P.H.D. d237820dex109.htm EX-10.9 79993
14 AMENDED AND RESTATED EMPLOYMENT AGREEMENT - PETRUS BEKKER M.D., P.H.D. d237820dex1010.htm EX-10.10 77621
15 STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE d237820dex1011.htm EX-10.11 222563
16 PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT d237820dex1012.htm EX-10.12 808229
17 AMENDMENT NO.1 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT d237820dex1013.htm EX-10.13 92490
18 AMENDMENT NO.2 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT d237820dex1014.htm EX-10.14 14962
19 AMENDMENT NO.3 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT d237820dex1015.htm EX-10.15 22426
20 AMENDMENT NO.4 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT d237820dex1016.htm EX-10.16 37774
21 AMENDMENT NO.5 TO PRODUCT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT d237820dex1017.htm EX-10.17 14957
22 AMENDMENT TO SERIES D PREFERRED STOCK SUBSCRIPTION AGREEMENT d237820dex1019.htm EX-10.19 14946
23 SERIES E PREFERRED STOCK SUBSCRIPTION AGREEMENT d237820dex1020.htm EX-10.20 104390
24 LOAN AND SECURITY AGREEMENT d237820dex1021.htm EX-10.21 133095
25 AMENDMENT NO.2 TO LOAN AND SECURITY AGREEMENT d237820dex1022.htm EX-10.22 37645
26 SUBSIDIARIES OF REGISTRANT d237820dex211.htm EX-21.1 1575
27 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d237820dex231.htm EX-23.1 1444
28 GRAPHIC g237820g14z62.jpg GRAPHIC 31793
29 GRAPHIC g237820g48v96.jpg GRAPHIC 73656
30 GRAPHIC g237820g68b14.jpg GRAPHIC 39974
31 GRAPHIC g237820g76d82.jpg GRAPHIC 22437
32 GRAPHIC g237820g87n20.jpg GRAPHIC 35173
  Complete submission text file 0001193125-11-271825.txt   5341315
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-177332 | Film No.: 111142303
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1